Vaxenta-Biotechnologies,-Inc.-logo

Vaxenta Biotechnologies, Inc.

Vaxenta is dedicated to pursuing a cancer-free society worldwide through the development & commercialization of safe, effective, and natural cancer therapies. Vaxenta Inc., is a biotechnology company, developing XenUvaX, a placenta based cancer vaccine immunotherapies for the treatment of cancer.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.vaxenta.com
Founded2013
Disease Focus
Development Stage
STOCK CODENon Listed
Address
San Diego
United States
Email
Contact Number
+1 858-227-9774

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]

Vaxentas XenUvax product is based in part on triggering immune responses towards cells involved in producing new blood vessels.